Landry Robert E bought REGN
January 4, 2024 · Form 4 insider transaction
Landry Robert E bought 500 shares of Regeneron Pharmaceuticals, Inc. at $378.98 per share, a transaction worth $189.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
500
Price
$378.98
Total value
$189.5K
InsiderLandry Robert E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 4, 2024
Filing dateJanuary 8, 2024
Shares owned after22,948
OwnershipDirect
10b5-1 planNo
AmendedNo